GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » Median PS Value

WIN-Partners Co (TSE:3183) Median PS Value : 円1,374.00 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. WIN-Partners Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円2613.16. WIN-Partners Co's 10-Year median PS Ratio is 0.5258. Therefore, the Median PS Value for today is 円1,374.00.

As of today (2024-05-21), WIN-Partners Co's share price is 円1155.00. WIN-Partners Co's Median PS Value is 円1,374.00. Therefore, WIN-Partners Co's Price to Median PS Value for today is 0.84.

The historical rank and industry rank for WIN-Partners Co's Median PS Value or its related term are showing as below:

TSE:3183' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.71   Med: 0.82   Max: 1.16
Current: 0.84

During the past 13 years, the highest Price to Median PS Value of WIN-Partners Co was 1.16. The lowest was 0.71. And the median was 0.82.

TSE:3183's Price-to-Median-PS-Value is ranked better than
61.11% of 54 companies
in the Medical Distribution industry
Industry Median: 0.92 vs TSE:3183: 0.84

WIN-Partners Co Median PS Value Historical Data

The historical data trend for WIN-Partners Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co Median PS Value Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,216.85 1,173.95 1,189.55 1,272.74 1,370.47

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,330.51 1,370.47 1,382.83 1,400.10 1,374.00

Competitive Comparison of WIN-Partners Co's Median PS Value

For the Medical Distribution subindustry, WIN-Partners Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Price-to-Median-PS-Value falls into.



WIN-Partners Co Median PS Value Calculation

WIN-Partners Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2613.16*0.5258
=1,374.00

10-Year Median PS Ratio is 0.5258.
WIN-Partners Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2613.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co  (TSE:3183) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

WIN-Partners Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=1155.00/1,374.00
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co Median PS Value Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines